z-logo
open-access-imgOpen Access
Telemedicine in French Memory Clinics During the COVID-19 Pandemic
Author(s) -
Alexandre Morin,
Thibaut Pressat-Laffouilhère,
Marie Sarazin,
Julien Lagarde,
Carole Roué-Jagot,
Pauline Olivieri,
Claire Paquet,
Emmanuel Cognat,
Julien Dumurgier,
Florence Pasquier,
Thibaut Lebouvier,
M. Ceccaldi,
Olivier Godefroy,
Olivier Martinaud,
Julien Grosjean,
Aline Zarea,
David Maltête,
David Wallon
Publication year - 2022
Publication title -
journal of alzheimer's disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-215459
Subject(s) - telemedicine , covid-19 , pandemic , dementia , medicine , emergency medicine , health care , disease , virology , outbreak , infectious disease (medical specialty) , economics , economic growth
This multicenter study was conducted in French memory clinics during the first COVID-2019 lockdown (March–May 2020). The objective was to evaluate the effect of a telemedicine consultation on treatment modification in dementia care. Among 874 patients who had a telemedicine consultation, 103 (10.7%) had treatment modifications, in particular those living with a relative or diagnosed with Alzheimer’s disease. A control group of patients referred March–May 2019 was also included. Treatment modification rate was similar between periods with an adjusted percentage difference of –4% (p = 0.27). Telemedicine consultations allowed treatment modifications with only a minor short-term negative impact on therapeutic strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here